Showing results (21-30 of 460) with videos related to
Sort By:
Pageof 46
Diabetes Care|June 1, 2014
Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1)Carol Wysham, Thomas Blevins, Richard Arakaki, et al.Diabetes, Obesity & Metabolism|March 21, 2019
Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2Simon R Heller, J Hans DeVries, Carol Wysham, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 28, 2015
TWO TREATMENT APPROACHES FOR HUMAN REGULAR U-500 INSULIN IN PATIENTS WITH TYPE 2 DIABETES NOT ACHIEVING ADEQUATE GLYCEMIC CONTROL ON HIGH-DOSE U-100 INSULIN THERAPY WITH OR WITHOUT ORAL AGENTS: A RANDOMIZED, TITRATION-TO-TARGET CLINICAL TRIALRobert C Hood, Richard F Arakaki, Carol Wysham, et al.Diabetes, Obesity & Metabolism|August 31, 2018
A post-hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus 100 U/mL (Gla-100) over wider nocturnal windows in individuals with type 2 diabetes on a basal-only insulin regimenGeremia B Bolli, Carol Wysham, Miles Fisher, et al.Journal of the American Veterinary Medical Association|December 15, 2021
What Is Your Diagnosis?Alexandra F Belotta, Sally Sukut, Jasmine Gu, et al.The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|March 18, 2026
Comparison of image quality in healthy dogs across 3 handheld ultrasound devices: Butterfly IQ+, Clarius C7HD3VET, and VScan AirSeth T Colby, Daniel Pang, Serge Chalhoub, et al.JAMA|July 4, 2017
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical TrialCarol Wysham, Anuj Bhargava, Louis Chaykin, et al.The Journal of Family Practice|June 19, 2018
The Pharmacokinetic Properties of Glucagon-like Peptide-1 Receptor Agonists and Their Mode and Mechanism of Action in Patients with Type 2 DiabetesJohn AndersonFrontline Gastroenterology|August 26, 2017
The future of gastroenterology training: instruction in technical skillsJohn AndersonPediatric Blood & Cancer|April 7, 2017
Unleashing the immune response against childhood solid cancersJohn AndersonPageof 46